Cellular and molecular determinants of cisplatin resistance
- 1 September 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10) , 1535-1542
- https://doi.org/10.1016/s0959-8049(98)00227-5
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts 1 1Edited by M. YanivJournal of Molecular Biology, 1997
- Cisplatin-induced apoptosis andp53 gene status in a cisplatin-resistant human ovarian carcinoma cell lineInternational Journal of Cancer, 1996
- Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesnaAnti-Cancer Drugs, 1994
- p53 tagged sites from human genomic DNAHuman Molecular Genetics, 1994
- Characterization of high mobility group protein binding to cisplatin-damaged DNABiochemical and Biophysical Research Communications, 1992
- ForewordCurrent Problems in Cancer, 1992
- Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical ResultsJNCI Journal of the National Cancer Institute, 1992
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexesChemico-Biological Interactions, 1987
- Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteusMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1978